Cluster analysis identifies distinct pathogenetic patterns in c3 glomerulopathies/immune complex–Mediated membranoproliferative GN

Journal of the American Society of Nephrology

Volumn 29, Issue 1, 2018, Pages 283-294

  Iatropoulos, Paraskevas ^a   Daina, Erica ^a   Curreri, Manuela ^a   Piras, Rossella ^a   Valoti, Elisabetta ^a   Mele, Caterina ^a   Bresin, Elena ^a   Gamba, Sara ^a   Alberti, Marta ^a   Breno, Matteo ^a   Perna, Annalisa ^a   Bettoni, Serena ^a   Sabadini, Ettore ^b   Murer, Luisa ^c   Vivarelli, Marina ^d   Noris, Marina ^a   Remuzzi, Giuseppe ^a,b,e   Bottanelli, L ^f   Donadelli, R ^f   Cuccarolo, P ^f   Abbate, M ^f   Carrara, C ^f   Cannata, A ^f   Ferrari, S ^f   Gaspari, F ^f   Stucchi, N ^f   Bassani, C ^f   Lena, M ^f   Omati, G ^f   Taruscia, D ^f   Bellantuono, R ^f   Giordano, M ^f   Messina, G ^f   Caruso, M ^f   Gotti, E ^f   Mescia, F ^f   Perticucci, E ^f   Schieppati, A ^f   Verdoni, L ^f   Berto, M ^f   Baraldi, O ^f   Montini, G ^f   Pasini, A ^f   Passler, W ^f   Degasperi, T ^f   Gaggiotti, M ^f   Gregorini, G ^f   Miglietti, N ^f   Guarnieri, A ^f   Cirami, L ^f   Roperto, R M ^f   Di Giorgio, G ^f   Barbano, G ^f   Innocenti, M L D ^f   Ghiggeri, G M ^f   Magnasco, A ^f   Rolla, D ^f   Casartelli, D ^f   Lambertini, D ^f   Maggio, M ^f   Cosci, P M ^f   Conti, G ^f   Amar, K ^f   Ardissino, G ^f   Marinosci, A ^f   Sinico, R A ^f   Montoli, A ^f   Bonucchi, D ^f   Facchini, F ^f   Furci, L ^f   Ferretti, A ^f   Nuzzi, F ^f   Pecoraro, C ^f   Visciano, B ^f   Canavese, C ^f   Radin, E ^f   Stratta, P ^f   Nordio, M ^f   Benetti, E ^f   Parolin, M ^f   Alberici, F ^f   Manenti, L ^f   Brugnano, R ^f   Manenti, F ^f   Capitanini, A ^f   Emma, F ^f   Massella, L ^f   Rosa, M ^f   Mazzon, M ^f   Basso, E ^f   Besso, L ^f   Lavacca, A ^f   Mella, A ^f   Bertero, M ^f   Coppo, R ^f   Peruzzi, L ^f   Porcellini, M G ^f   Piccoli, G B ^f   Clari, R ^f   Pasi, A ^f   Gangemi, C ^f   Alfandary, H ^f   Dagan, A ^f   Conceicao M ^f   Sameiro, F M ^f   Croze, L ^f   Malvezzi, P ^f   Tsygin, A ^f   Zelan, B ^f   Nastasi, ^f   more..

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b Unit of Nephrology and Dialysis   (Italy)

^c UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^d BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; NEPHRITIC FACTOR;

ADOLESCENT; ADULT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CLUSTER ANALYSIS; COMPLEMENT ACTIVATION; COMPLEMENT BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GLOMERULOPATHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; PATHOGENESIS; PRIORITY JOURNAL; SOLID; SURVIVAL; YOUNG ADULT; ALGORITHM; BLOOD; CHILD; COMPLICATION; GENETICS; IMMUNE COMPLEX DISEASE; IMMUNOLOGY; METABOLISM; NEPHROTIC SYNDROME; PRESCHOOL CHILD;

ADOLESCENT; ADULT; ALGORITHMS; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; COMPLEMENT ACTIVATION; COMPLEMENT C3; COMPLEMENT C3 NEPHRITIC FACTOR; COMPLEMENT C3-C5 CONVERTASES; FEMALE; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HUMANS; IMMUNE COMPLEX DISEASES; MALE; NEPHROTIC SYNDROME; YOUNG ADULT;

EID: 85040097941     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2017030258     Document Type: Article

References (32)

1. Cook HT, Pickering MC: Histopathology of MPGN and C3 glomerulopathies. Nat Rev Nephrol 11: 14–22, 2015
2. Sethi S, Fervenza FC: Membranoproliferative glomerulonephritis: Pathogenetic heterogeneity and proposal for a new classification. Semin Nephrol 31: 341–348, 2011
3. Pickering MC, D’Agati VD, Nester CM, Smith RJ, Haas M, Appel GB, Alpers CE, Bajema IM, Bedrosian C, Braun M, Doyle M, Fakhouri F, Fervenza FC, Fogo AB, Frémeaux-Bacchi V, Gale DP, Goicoechea de Jorge E, Griffin G, Harris CL, Holers VM, Johnson S, Lavin PJ, Medjeral-Thomas N, Paul Morgan B, Nast CC, Noel LH, Peters DK, Rodríguez de Córdoba S, Servais A, Sethi S, Song WC, Tamburini P, Thurman JM, Zavros M, Cook HT: C3 glomerulopathy: Consensus report. Kidney Int 84: 1079–1089, 2013
4. Hou J, Markowitz GS, Bomback AS, Appel GB, Herlitz LC, Barry Stokes M, D’Agati VD: Toward a working definition of C3 glomerulopathy by immunofluorescence. Kidney Int 85: 450–456, 2014
5. Figuères ML, Frémeaux-Bacchi V, Rabant M, Galmiche L, Marinozzi MC, Grünfeld JP, Noël LH, Servais A: Heterogeneous histologic and clinical evolution in 3 cases of dense deposit disease with long-term follow-up. Hum Pathol 45: 2326–2333, 2014
6. Habbig S, Mihatsch MJ, Heinen S, Beck B, Emmel M, Skerka C, Kirschfink M, Hoppe B, Zipfel PF, Licht C: C3 deposition glomerulopathy due to a functional factor H defect. Kidney Int 75: 1230–1234, 2009
7. Bomback AS, Appel GB: Pathogenesis of the C3 glomerulopathies and reclassification of MPGN. Nat Rev Nephrol 8: 634–642, 2012
8. Licht C, Heinen S, Józsi M, Löschmann I, Saunders RE, Perkins SJ, Waldherr R, Skerka C, Kirschfink M, Hoppe B, Zipfel PF: Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II). Kidney Int 70: 42–50, 2006
9. Servais A, Noël LH, Roumenina LT, Le Quintrec M, Ngo S, Dragon-Durey MA, Macher MA, Zuber J, Karras A, Provot F, Moulin B, Grünfeld JP, Niaudet P, Lesavre P, Frémeaux-Bacchi V: Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies. Kidney Int 82: 454–464, 2012
10. Iatropoulos P, Noris M, Mele C, Piras R, Valoti E, Bresin E, Curreri M, Mondo E, Zito A, Gamba S, Bettoni S, Murer L, Fremeaux-Bacchi V, Vivarelli M, Emma F, Daina E, Remuzzi G: Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcome. Mol Immunol 71: 131–142, 2016
11. Marinozzi MC, Roumenina LT, Chauvet S, Hertig A, Bertrand D, Olagne J, Frimat M, Ulinski T, Deschênes G, Burtey S: Anti-factor B and anti-C3b autoantibodies in C3 glomerulopathy and Ig-associated membranoproliferative GN. J Am Soc Nephrol 28: 1603–1613, 2017
12. van Rooden SM, Heiser WJ, Kok JN, Verbaan D, van Hilten JJ, Marinus J: The identification of Parkinson’s disease subtypes using cluster analysis: A systematic review. Mov Disord 25: 969–978, 2010
13. Vogt W, Nagel D: Cluster analysis in diagnosis. Clin Chem 38: 182–198, 1992
14. Lötvall J, Akdis CA, Bacharier LB, Bjermer L, Casale TB, Custovic A, Lemanske Jr. RF, Wardlaw AJ, Wenzel SE, Greenberger PA: Asthma endotypes: A new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol 127: 355–360, 2011
15. Burgel PR, Paillasseur JL, Caillaud D, Tillie-Leblond I, Chanez P, Escamilla R, Court-Fortune I, Perez T, Carré P, Roche N; Initiatives BPCO Scientific Committee: Clinical COPD phenotypes: A novel approach using principal component and cluster analyses. Eur Respir J 36: 531–539, 2010
16. Howrylak JA, Fuhlbrigge AL, Strunk RC, Zeiger RS, Weiss ST, Raby BA; Childhood Asthma Management Program Research Group: Classification of childhood asthma phenotypes and long-term clinical responses to inhaled anti-inflammatory medications. J Allergy Clin Immunol 133: 1289–1300, 2014
17. Paixão-Cavalcante D, López-Trascasa M, Skattum L, Giclas PC, Goodship TH, de Córdoba SR, Truedsson L, Morgan BP, Harris CL: Sensitive and specific assays for C3 nephritic factors clarify mechanisms underlying complement dysregulation. Kidney Int 82: 1084–1092, 2012
18. Marinozzi M-C, Chauvet S, Le Quintrec M, Mignotet M, Petitprez F, Legendre C, Cailliez M, Deschenes G, Fischbach M, Karras A, Nobili F, Pietrement C, Dragon-Durey MA, Fakhouri F, Roumenina LT, Fremeaux-Bacchi V: C5 nephritic factors drive the biological phenotype of C3 glomerulopathies [published online ahead of print July 13, 2017]. Kidney Int doi:10.1016/j.kint.2017.04.017
19. Noris M, Remuzzi G: Overview of complement activation and regulation. Semin Nephrol 33: 479–492, 2013
20. Zhang Y, Nester CM, Martin B, Skjoedt MO, Meyer NC, Shao D, Borsa N, Palarasah Y, Smith RJ: Defining the complement biomarker profile of C3 glomerulopathy. Clin J Am Soc Nephrol 9: 1876–1882, 2014
21. Noris M, Remuzzi G: Glomerular diseases dependent on complement activation, including atypical hemolytic uremic syndrome, membranoproliferative glomerulonephritis, and C3 glomerulopathy: Core Curriculum 2015. Am J Kidney Dis 66: 359–375, 2015
22. Schmitt H, Bohle A, Reineke T, Mayer-Eichberger D, Vogl W: Long-term prognosis of membranoproliferative glomerulonephritis type I. Significance of clinical and morphological parameters: An investigation of 220 cases. Nephron 55: 242–250, 1990
23. Medjeral-Thomas NR, O’Shaughnessy MM, O’Regan JA, Traynor C, Flanagan M, Wong L, Teoh CW, Awan A, Waldron M, Cairns T, O’Kelly P, Dorman AM, Pickering MC, Conlon PJ, Cook HT: C3 glomerulopathy: Clinicopathologic features and predictors of outcome. Clin J Am Soc Nephrol 9: 46–53, 2014
24. Chauvet S, Roumenina LT, Bruneau S, Marinozzi MC, Rybkine T, Schramm EC, Java A, Atkinson JP, Aldigier JC, Bridoux F: A familial C3GN secondary to defective C3 regulation by complement receptor 1 and factor H. J Am Soc Nephrol 27: 1665–1677, 2016
25. Józsi M, Tortajada A, Uzonyi B, Goicoechea de Jorge E, Rodríguez de Córdoba S: Factor H-related proteins determine complement-activating surfaces. Trends Immunol 36: 374–384, 2015
26. Malik TH, Lavin PJ, Goicoechea de Jorge E, Vernon KA, Rose KL, Patel MP, de Leeuw M, Neary JJ, Conlon PJ, Winn MP, Pickering MC: A hybrid CFHR3-1 gene causes familial C3 glomerulopathy. J Am Soc Nephrol 23: 1155–1160, 2012
27. Xiao X, Ghossein C, Tortajada A, Zhang Y, Meyer N, Jones M, Borsa NG, Nester CM, Thomas CP, de Córdoba SR, Smith RJ: Familial C3 glomerulonephritis caused by a novel CFHR5-CFHR2 fusion gene. Mol Immunol 77: 89–96, 2016
28. Bomback AS, Smith RJ, Barile GR, Zhang Y, Heher EC, Herlitz L, Stokes MB, Markowitz GS, D’Agati VD, Canetta PA, Radhakrishnan J, Appel GB: Eculizumab for dense deposit disease and C3 glomerulonephritis. Clin J Am Soc Nephrol 7: 748–756, 2012
29. Ricklin D, Lambris JD: New milestones ahead in complement-targeted therapy. Semin Immunol 28: 208–222, 2016
30. Risitano AM, Notaro R, Pascariello C, Sica M, del Vecchio L, Horvath CJ, Fridkis-Hareli M, Selleri C, Lindorfer MA, Taylor RP, Luzzatto L, Holers VM: The complement receptor 2/factor H fusion protein TT30 protects paroxysmal nocturnal hemoglobinuria erythrocytes from complement-mediated hemolysis and C3 fragment. Blood 119: 6307–6316, 2012
31. Frémeaux-Bacchi V, Weiss L, Brun P, Kazatchkine MD: Selective disappearance of C3NeF IgG autoantibody in the plasma of a patient with membranoproliferative glomerulonephritis following renal transplantation. Nephrol Dial Transplant 9: 811–814, 1994
32. Noris M, Caprioli J, Bresin E, Mossali C, Pianetti G, Gamba S, Daina E, Fenili C, Castelletti F, Sorosina A, Piras R, Donadelli R, Maranta R, van der Meer I, Conway EM, Zipfel PF, Goodship TH, Remuzzi G: Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephrol 5: 1844–1859, 2010